AnPac Bio-Medical Science Co., Ltd. Soared
Fri, Aug 07, 2020 at 05:30 PM
AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) soared at $7.6, representing a gain of 38.4%. The stock appeared on our News Catalysts scanner on Fri 07 Aug 20 at 08:19 AM in the 'MISCELLANEOUS' category. From Thu 23 Jul 20, the stock recorded 50.00% Up Days and 54.55% Green Days
About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.
Top 10 Gainers:
- Conduent Incorporated (CNDT:NASDAQ), 82.74%
- Addex Therapeutics Ltd (ADXN:NASDAQ), 70.45%
- Groupon, Inc. (GRPN:NASDAQ), 56.66%
- OpGen, Inc. (OPGN:NASDAQ), 52.49%
- Huttig Building Products, Inc. (HBP:NASDAQ), 52.12%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 50.59%
- Sirius International Insurance Group, Ltd. (SG:NASDAQ), 45.42%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 44.83%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 38.43%
- ShotSpotter, Inc. (SSTI:NASDAQ), 28.29%